scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41388-018-0649-6 |
P698 | PubMed publication ID | 30617303 |
P2093 | author name string | Chunling Yi | |
Shannon M White | |||
Shigekazu Murakami | |||
P2860 | cites work | Yorkie Regulates Neurodegeneration Through Canonical Pathway and Innate Immune Response. | Q51181872 |
Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies. | Q52568331 | ||
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies. | Q52596335 | ||
When worlds collide: Th17 and Treg cells in cancer and autoimmunity. | Q52689973 | ||
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. | Q53206297 | ||
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. | Q53334281 | ||
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity | Q57170572 | ||
RAP2 mediates mechanoresponses of the Hippo pathway | Q59050629 | ||
Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells | Q59066462 | ||
Mst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus | Q61207271 | ||
Regulation of the Hippo pathway in cancer biology | Q88229231 | ||
Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels | Q89777814 | ||
Mst1-FoxO signaling protects Naïve T lymphocytes from cellular oxidative stress in mice | Q21091167 | ||
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP) | Q24293710 | ||
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control | Q24299106 | ||
Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion | Q24299123 | ||
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway | Q24307937 | ||
Mst1 directs Myosin IIa partitioning of low and higher affinity integrins during T cell migration | Q27313904 | ||
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy | Q28078667 | ||
Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction | Q30355193 | ||
Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes | Q30487658 | ||
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression | Q30754497 | ||
YAP regulates cell mechanics by controlling focal adhesion assembly | Q30852416 | ||
MST1/MST2 Protein Kinases: Regulation and Physiologic Roles | Q33821181 | ||
YAP determines the cell fate of injured mouse hepatocytes in vivo | Q33891084 | ||
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy | Q33933665 | ||
A complex secretory program orchestrated by the inflammasome controls paracrine senescence | Q34037190 | ||
Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma | Q34246014 | ||
The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. | Q34333492 | ||
The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity | Q34546530 | ||
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis | Q35086389 | ||
The phenotype of human STK4 deficiency | Q35885278 | ||
The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes. | Q35894211 | ||
Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell | Q36170597 | ||
Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity | Q36200269 | ||
STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma | Q36266490 | ||
Mammalian Sterile 20-like Kinase 1 (Mst1) Enhances the Stability of Forkhead Box P3 (Foxp3) and the Function of Regulatory T Cells by Modulating Foxp3 Acetylation. | Q36407224 | ||
A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness | Q36438072 | ||
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression | Q36447669 | ||
Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila. | Q36521487 | ||
Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation | Q36891691 | ||
The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. | Q37010249 | ||
LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development. | Q37061204 | ||
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy | Q37072889 | ||
MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival | Q37298578 | ||
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. | Q37331580 | ||
Mycobacterium tuberculosis-triggered Hippo pathway orchestrates CXCL1/2 expression to modulate host immune responses | Q37435081 | ||
Transcriptional Control of Dendritic Cell Development. | Q37468541 | ||
Dendritic cell MST1 inhibits Th17 differentiation | Q37630340 | ||
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy | Q37736296 | ||
Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma | Q38401343 | ||
Rab13 acts downstream of the kinase Mst1 to deliver the integrin LFA-1 to the cell surface for lymphocyte trafficking. | Q38970419 | ||
Molecular requirements for sensing of intracellular microbial nucleic acids by the innate immune system. | Q38983257 | ||
Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease | Q39031565 | ||
A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. | Q39108970 | ||
YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKɛ-mediated phosphorylation. | Q39155971 | ||
The role of stromal cancer-associated fibroblasts in pancreatic cancer. | Q39205210 | ||
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway | Q39394211 | ||
Myeloid suppressor cells in cancer and autoimmunity | Q39448441 | ||
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. | Q40050674 | ||
Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade | Q40272124 | ||
Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF. | Q40885761 | ||
Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. | Q41858851 | ||
Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo | Q41892098 | ||
Single tumor-initiating cells evade immune clearance by recruiting type II macrophages | Q41957741 | ||
Roles for Innate Immunity in Combination Immunotherapies | Q41996352 | ||
Modulating F-actin organization induces organ growth by affecting the Hippo pathway | Q42760112 | ||
A cell-intrinsic role for Mst1 in regulating thymocyte egress. | Q43289467 | ||
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. | Q47234408 | ||
Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma | Q47864262 | ||
Lessons from CTLA-4 deficiency and checkpoint inhibition | Q47955601 | ||
The Epithelial Circumferential Actin Belt Regulates YAP/TAZ through Nucleocytoplasmic Shuttling of Merlin | Q47972634 | ||
Mechanical regulation of a molecular clutch defines force transmission and transduction in response to matrix rigidity. | Q48043368 | ||
YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma. | Q48139568 | ||
The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells. | Q48144535 | ||
Targeting IRF3 as a YAP agonist therapy against gastric cancer. | Q48232435 | ||
Mutual dependence of the MRTF-SRF and YAP-TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics | Q48277126 | ||
YAP regulates PD-L1 expression in human NSCLC cells. | Q49569691 | ||
The Hippo pathway component TAZ promotes immune evasion in human cancer through PD-L1. | Q50019997 | ||
Targeting myeloid cells in the tumor sustaining microenvironment. | Q50055744 | ||
The Hippo pathway in organ development, homeostasis, and regeneration. | Q50116622 | ||
Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism. | Q50896241 | ||
P433 | issue | 16 | |
P304 | page(s) | 2899-2909 | |
P577 | publication date | 2019-01-07 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity | |
P478 | volume | 38 |
Q95320552 | Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy |
Q94476088 | Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment |
Q97540587 | KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury |
Q89698064 | Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages |
Q91921479 | Serum exosomal microRNA transcriptome profiling in subacute spinal cord injured rats |
Q99371197 | Serum exosomal microRNA transcriptome profiling in subacute spinal cord injured rats |
Q90482955 | The HIPPO pathway in gynecological malignancies |
Q84957646 | The Hippo Pathway and Viral Infections |
Search more.